Tag: acquired immune deficiency syndrome

HIV Vaccine Fails, Prompting Calls for More PrEP

Last year, Katherine Gill, MD, an HIV prevention researcher in Cape Town, South Africa, realized how jaded she’d become to vaccine research when the Pfizer...

CAB/RPV LA Not for Everyone

“One of the most important considerations before switching HIV patients to injectable long-acting cabotegravir/rilpivirine [CAB/RPV LA; Cabenuva, ViiV Healthcare] is for the patient and the...

Cryptococcal Meningitis: Single-Dose Regimen Noninferior

A single high dose of the antifungal agent liposomal amphotericin B (L-AmB; AmBisome, Gilead Sciences), with a background regimen of flucytosine and fluconazole, is noninferior...

HIV Acquisition on PrEP Rare, With Some Drug Resistance

Out of an estimated 104,000 people offered HIV preexposure prophylaxis (PrEP) to protect themselves from HIV, just 14 people acquired a strain of HIV resistant...

Failed viral suppression in CAB/RPV linked to 3 Risk Factors

A body mass index (BMI) ≥30 kg/m2, rilpivirine resistance–associated mutations, and the HIV-1 subtype A6/A1 can raise a person’s risk for confirmed virologic failure (CVF)...

Dolutegravir Confirmed as Effective Second-Line HIV Therapy

Dolutegravir and ritonavir-boosted darunavir are equally effective second-line treatments for HIV-1, even for patients with resistance to nucleoside reverse-transcriptase inhibitors (NRTIs) in the regimen, a...

Lenacapavir Shows Viral Suppression in Drug-Resistant HIV

Dr Jean-Michel Molina The long-acting drug lenacapavir, a first-in-class capsid inhibitor, shows sustained viral suppression in a small cohort of heavily treatment-experienced patients with multidrug-resistant...

HIV Increases Risk for Severe COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. HIV increases the risk for severe COVID-19 by 6% and the...

Should Feds Allow a Therapy That Pays Meth Users to Abstain?

In his multiple attempts to overcome a methamphetamine addiction that ground through two decades of his life, Tyrone Clifford Jr. remembers well the closest he...

Is HIV Criminalization the No. 1 Barrier to Ending the Epidemic?

For many people, being told that they are HIV positive is no longer a death sentence. But for Robert Suttle, a Black gay man and...

Biden’s CDC Director Has Long Used Data to Save Lives

In early December, Dr. Katy Stephenson was watching TV with her family and scrolling through Twitter when she saw a tweet that made her shout. “I said...

In Public Health’s Response to COVID, Fear Tactics Are a Misstep

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.   You probably still remember public service ads that scared you:...

Dr Anthony Fauci Documentary in the Works

Dr. Anthony Fauci was a respected and dedicated public servant, but one who could walk the streets without turning heads or being recognized. Then COVID-19...

Infectious Diseases ‘Giant’ John Bartlett: His ‘Impact Will Endure’

Dr John Bartlett John G. Bartlett, MD, professor emeritus at the Johns Hopkins University School of Medicine and a prominent leader and instructor in infectious...

Score Aids Treatment Decision in Mild Large-Vessel Stroke

Patents who experience an ischemic stroke and who have a large-vessel occlusion but only mild symptoms are at “substantial” risk for early neurologic deterioration after...

Bedside EEG Test Aids Prognosis in Brain Injury Patients

A simple, noninvasive electroencephalogram (EEG) may help detect residual cognition in unresponsive patients who have experienced a traumatic brain injury (TBI), results of a new...

Many Health Plans Must Cover Full Cost of HIV Prevention Drugs

Private insurance will be required to cover drugs such as Truvada, which offer protection against HIV infection, without making plan members share the cost. Ted...

Drug Combo Injection Every 8 Weeks Safe, Effective in HIV: Study

NEW YORK (Reuters Health) – Cabotegravir plus rilpivirine given by injection every eight weeks appeared to be a promising new therapeutic option for people living...

Biden’s Pick to Head CDC Welcomed by Public Health Experts

Experts in public health offered quick praise for President-elect Joe Biden’s choice of a noted HIV expert to lead the Centers for Disease Control and...

How Much Does a Mask Protect You? The Jury’s Still Out

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Yes, you should still wear a mask. You may have heard...

HIV PrEP Prescriptions Often Go Unfilled

Same-day HIV pre-exposure prophylaxis (PrEP) prescriptions and insurance navigation services led 70% of people at a Detroit sexually transmitted infection clinic to ask for a...

HCV Care Can Learn a Thing or Two From the HIV Experience

Individuals living with hepatitis C virus (HCV) infection face several challenges in accessing care, many of which are shared by patients in the HIV community....

Aging With HIV Adds to Comorbidity Burden

The age of antiretroviral therapy (ART) for HIV is in its third decade, and many of the patients who live in areas of the world...

HIV PrEP Referrals Lag for Black MSM, Trans Adults

State health departments were most likely to refer heterosexual adults for HIV preexposure prophylaxis (PrEP) appointments and least likely to refer transgender and Black adults,...

Starting ART Before MD Visit Speeds Care

Time to enrollment in HIV treatment dropped by 53% when clinicians sent people new to HIV treatment home from intake with a bottle of universal...